Comparing Vitamin D Results and Acceptability of Sampling Obtained From Dried Blood Spot, Tasso+ Capillary Sampling, and Venous Blood.

ConditionVitamin D
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorThe Royal Wolverhampton Hospitals NHS Trust

About this trial

This study will evaluate the performance and acceptability of different sampling methods for measuring vitamin D, specifically 25-hydroxyvitamin D₂ and 25-hydroxyvitamin D₃.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Adults aged 18 years or older.

Current healthcare staff or staff volunteers.

Already consented to use the routine dried blood spot (DBS) vitamin D service.

Able and willing to provide all three sample types- routine DBS finger-prick sample, a Tasso+ upper-arm self-collected capillary sample, and a venous blood sample taken by a trained Trust phlebotomist.

Disqualifiers

Under 18 years of age

Not a member of staff or staff volunteer

Known difficulty with blood sampling, such as a history of fainting, severe needle phobia, or conditions that make venepuncture unsafe.

Skin conditions or injuries on the upper arm that would prevent safe use of the Tasso+ device.

Trial design

Design model

Single group

Treatments tested in this trial

  • Vit D Tasso+

    Device

    Blood collected using Tasso device

Treatment groups

35 Participants
are divided into 1 treatment group
Group A: Vitamin D samplingExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Agreement between Tasso+ capillary serum and venous serum 25(OH)D

Continuous 25(OH)D₂ and 25(OH)D₃ concentrations (nmol/L)

Time frame
From Study start date for up to 12 months

Secondary outcomes

1

User acceptability

Pain, on a scale from 1-5 1= no pain. 5= worse pain

Time frame
From Study start date for up to 12 months
2

User acceptability

Ease of Use: how easy or difficult each method was to complete 1= Very difficult, 5=Very easy Dried Bloodspot Venepuncture Tasso+

Time frame
From study start date to 12 months
3

User acceptability

Clarity of Instructions: how clear were the instructions you were given? 1= Not clear at all, 5=Extremely clear Dried Bloodspot Venepuncture Tasso+

Time frame
From Study start date for up to 12 months
4

User acceptability

Safety: How safe did each method feel to you ? 1= Very unsafe, 5=Very safe Dried Bloodspot Venepuncture Tasso+

Time frame
From Study start date for up to 12 months

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: